e-learning
resources
Virtual 2021
05.09.2021
Pathophysiology and clinical consequences of obstructive sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comorbidities associated with sleep apnea - a nested case-control study in hospitalized patients
F. Baty (St. Gallen, Switzerland), M. Moser (St. Gallen, Switzerland), O. Schoch (St. Gallen, Switzerland), M. Brutsche (St. Gallen, Switzerland)
Source:
Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea
Session:
Pathophysiology and clinical consequences of obstructive sleep apnoea
Session type:
E-poster
Number:
375
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Baty (St. Gallen, Switzerland), M. Moser (St. Gallen, Switzerland), O. Schoch (St. Gallen, Switzerland), M. Brutsche (St. Gallen, Switzerland). Comorbidities associated with sleep apnea - a nested case-control study in hospitalized patients. 375
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Acromegaly in sleep apnoea patients: a large observational study in 755 patients
Source: Eur Respir J 2016; 48: 1489-1492
Year: 2016
Obstructive sleep apnoea is not a risk factor for incident hospitalised depression: a historical cohort study
Source: Eur Respir J, 49 (6) 1601361; 10.1183/13993003.01361-2016
Year: 2017
Gout increases the risk of coronary heart disease among patients with obstructive sleep apnea: A nationwide population-based cohort study
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015
Hypertension prevalence in obstructive sleep apnoea and sex: a population-based case-control study
Source: Eur Respir J 2006; 27: 564-570
Year: 2006
Sleep apnoea syndrome is highly prevalent in pacemaker patients: a multicenter polysomnographic study in 98 patients
Source: Annual Congress 2004 - Non-CPAP therapy for OSA
Year: 2004
Severe obstructive sleep apnea syndrome in elderly population: A prospective study of 80 patients
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies
Year: 2015
Symptoms of snoring and sleep apnea in women – a population-based study
Source: Annual Congress 2008 - Socioepidemiological studies in obstructive sleep apnoea
Year: 2008
Ventilatory phenotypes of sleep apnoea subtypes at a chronic delay following a first ischemic stroke: a cross-sectional analysis of a prospective clinical-based cohort study
Source: Sleep and Breathing Conference 2021
Year: 2021
Do perinatal factors associate with obstructive sleep apnea? A retrospective study of snoring children
Source: Sleep and Breathing Conference 2021
Year: 2021
Treatment of central sleep apnea in patients with heart failure: A retrospective observational study
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012
Obstructive sleep apnea increases the risk of injuries- A nationwide population-based retrospective study
Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view
Year: 2019
Cardiovascular, metabolic prognosis and mortality of the positional sleep apnea syndrome: An historical cohort study including 240 patients
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Prevalence of obstructive sleep apnoea syndrome among patients of general hospital: epidemiological study
Source: Eur Respir J 2001; 18: Suppl. 33, 256s
Year: 2001
Non apnea sleep disorder associates with higher risk of injuries- A 13-year follow up nationwide population-based cohort study
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019
Does CPAP therapy affect sleep time in patients with obstructive sleep apnea? A prospective study
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016
Mortality and morbidity in obstructive sleep apnoea–hypopnoea syndrome: results from a 30-year prospective cohort study
Source: ERJ Open Res, 6 (3) 00057-2020; 10.1183/23120541.00057-2020
Year: 2020
Moderate obstructive sleep apnea and cardiovascular outcomes in elder patients: a propensity score matched, multicentric study (CPAGE-MODE study)
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021
Self-reported sleep apnoea and mortality in patients from the Swedish Obese Subjects study
Source: Eur Respir J 2011; 38: 1349-1354
Year: 2011
Association of obstructive sleep apnea with female infertility - A 13-year nationwide population-based retrospective study
Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view
Year: 2019
Obstructive sleep apnoea as a risk factor for incident metabolic syndrome: a joined Episono and HypnoLaus prospective cohorts study
Source: Eur Respir J, 52 (5) 1801150; 10.1183/13993003.01150-2018
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept